Richard J Markham's Net Worth
$0
Who is Richard J Markham?
Richard J Markham does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Anacor Pharmaceuticals Inc, CoLucid Pharmaceuticals, Inc., Aviragen Therapeutics, Inc., ACURA PHARMACEUTICALS, INC, and NephroGenex, Inc..
SEC CIK
Richard J Markham's CIK is 0001362743
Past Insider Trading and Trends
2011 was Richard J Markham's most active year for acquiring shares with 3 total transactions. Richard J Markham's most active month to acquire stocks was the month of December. 2011 saw Richard J Markham paying a total of $0.00 for 60,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Anacor Pharmaceuticals Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
∞
| 1.56M |
—
|
—
| 1.56M |
Nov 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CoLucid Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.55M |
—
|
—
| 1.55M |
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12 - May 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aviragen Therapeutics, Inc. (VXRT) Snapshot price: $0.88
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
∞
| 30.79M |
—
|
—
| 30.79M |
Feb 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACURA PHARMACEUTICALS, INC (ACUR) Snapshot price: $0.05
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| -100.00% | -10.92K |
$4.77 | -$52,102.71 |
0
|
Mar 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| -59.13% | -15.80K |
$7.42 | -$117,300.00 | 10.92K |
May 22 - May 26
| |||
Form 4
| -18.34% | -6.00K |
$7.34 | -$44,040.00 | 26.72K |
May 20
| |||
Form 4
| -3.93% | -1.34K |
$7.04 | -$9,419.52 | 32.72K |
May 15
| |||
Form 4
| -17.10% | -7.03K |
$7.05 | -$49,547.40 | 34.06K |
May 13
| |||
Form 4
| -36.38% | -23.50K |
$6.92 | -$162,597.00 | 41.09K |
May 7 - May 8
| |||
Form 4
| -15.78% | -12.10K |
$6.79 | -$82,159.00 | 64.59K |
May 6
| |||
Form 4
| -31.34% | -35.00K |
$7.11 | -$248,850.00 | 76.69K |
Mar 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NephroGenex, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||